** Shares of IDT Australia IDT.AX rise as much as 4.9% to A$0.043, their highest since April 16
** Pharmaceutical producer says FY26 EBITDA loss forecast to narrow to A$1.5 million-A$2 million ($1.08 million-1.44 million), improvement of 68%-76% on FY25
** Expect to deliver best Q4 result since the start of transformation program over two years ago - IDT
** Around 176,000 shares change hands, nearly 1.2x 30-day average
** IDT down 17.7% YTD
($1 = 1.3922 Australian dollars)
(Reporting by Keshav Singh Chundawat in Bengaluru)
((Keshav.singhchundawat@thomsonreuters.com))